Cargando…

Potential application of endocannabinoid system agents in neuropsychiatric and neurodegenerative diseases—focusing on FAAH/MAGL inhibitors

The endocannabinoid system (ECS) has received extensive attention for its neuroprotective effect on the brain. This system comprises endocannabinoids, endocannabinoid receptors, and the corresponding ligands and proteins. The molecular players involved in their regulation and metabolism are potentia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ren, Si-yu, Wang, Zhen-zhen, Zhang, Yi, Chen, Nai-hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Singapore 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608191/ https://www.ncbi.nlm.nih.gov/pubmed/32203086 http://dx.doi.org/10.1038/s41401-020-0385-7

Ejemplares similares

Therapeutic endocannabinoid augmentation for mood and anxiety disorders: comparative profiling of FAAH, MAGL and dual inhibitors
por: Bedse, Gaurav, et al.
Publicado: (2018)

Hexafluoroisopropyl Carbamates as Selective MAGL and Dual MAGL/FAAH Inhibitors: Biochemical and Physicochemical Properties
por: Barth, Maximilian, et al.
Publicado: (2022)

Potent dual MAGL/FAAH inhibitor AKU-005 engages endocannabinoids to diminish meningeal nociception implicated in migraine pain
por: Della Pietra, Adriana, et al.
Publicado: (2023)

Distinct Activity of Endocannabinoid-Hydrolyzing Enzymes MAGL and FAAH in Key Regions of Peripheral and Central Nervous System Implicated in Migraine
por: Della Pietra, Adriana, et al.
Publicado: (2021)

Dual Inhibition of FAAH and MAGL Counteracts Migraine-like Pain and Behavior in an Animal Model of Migraine
por: Greco, Rosaria, et al.
Publicado: (2021)

The endocannabinoid hydrolase FAAH is an allosteric enzyme
por: Dainese, Enrico, et al.
Publicado: (2020)

Author Correction: The endocannabinoid hydrolase FAAH is an allosteric enzyme
por: Dainese, Enrico, et al.
Publicado: (2020)

Beyond the Canonical Endocannabinoid System. A Screening of PPAR Ligands as FAAH Inhibitors
por: Brunetti, Leonardo, et al.
Publicado: (2020)

Weak Hypotensive Effect of Chronic Administration of the Dual FAAH/MAGL Inhibitor JZL195 in Spontaneously Hypertensive Rats as Revealed by Area under the Curve Analysis
por: Toczek, Marek, et al.
Publicado: (2023)

Potential of Fatty Acid Amide Hydrolase (FAAH), Monoacylglycerol Lipase (MAGL), and Diacylglycerol Lipase (DAGL) Enzymes as Targets for Obesity Treatment: A Narrative Review
por: Matheson, Justin, et al.
Publicado: (2021)

A polymorphism in the gene of the endocannabinoid-degrading enzyme FAAH (FAAH C385A) is associated with emotional–motivational reactivity
por: Conzelmann, Annette, et al.
Publicado: (2012)

Endocannabinoid Regulation of Acute and Protracted Nicotine Withdrawal: Effect of FAAH Inhibition
por: Cippitelli, Andrea, et al.
Publicado: (2011)

New Disulfiram Derivatives as MAGL-Selective Inhibitors
por: Omran, Ziad
Publicado: (2021)

The endocannabinoid gene faah2a modulates stress-associated behavior in zebrafish
por: Krug, Randall G., et al.
Publicado: (2018)

FAAH and CNR1 Polymorphisms in the Endocannabinoid System and Alcohol-Related Sleep Quality
por: Soundararajan, Soundarya, et al.
Publicado: (2021)

FAAH inhibitors in the limelight, but regrettably
por: Mallet, Christophe, et al.
Publicado: (2016)

A potent and selective inhibitor for the modulation of MAGL activity in the neurovasculature
por: Kemble, Alicia M., et al.
Publicado: (2022)

Potential Therapeutic Value of a Novel FAAH Inhibitor for the Treatment of Anxiety
por: Marco, Eva M., et al.
Publicado: (2015)

Targeting the Endocannabinoid System for Neuroprotection: A (19)F-NMR Study of a Selective FAAH Inhibitor Binding with an Anandamide Carrier Protein, HSA
por: Zhuang, Jianqin, et al.
Publicado: (2013)

An endocannabinoid catabolic enzyme FAAH and its paralogs in an early land plant reveal evolutionary and functional relationship with eukaryotic orthologs
por: Haq, Imdadul, et al.
Publicado: (2020)

Localization of the cannabinoid CB1 receptor and the 2-AG synthesizing (DAGLα) and degrading (MAGL, FAAH) enzymes in cells expressing the Ca(2+)-binding proteins calbindin, calretinin, and parvalbumin in the adult rat hippocampus
por: Rivera, Patricia, et al.
Publicado: (2014)

Brain structural changes in cannabis dependence: association with MAGL
por: Manza, Peter, et al.
Publicado: (2019)

Analgesic effects of FAAH inhibitor in the insular cortex of nerve-injured rats
por: Jee Kim, Min, et al.
Publicado: (2018)

Small Molecules: Therapeutic Application in Neuropsychiatric and Neurodegenerative Disorders
por: Schiavone, Stefania, et al.
Publicado: (2018)

Therapeutic Applications of Cysteamine and Cystamine in Neurodegenerative and Neuropsychiatric Diseases
por: Paul, Bindu D., et al.
Publicado: (2019)

Discovery of Monoacylglycerol Lipase (MAGL) Inhibitors Based on a Pharmacophore-Guided Virtual Screening Study
por: Jha, Vibhu, et al.
Publicado: (2020)

Endocannabinoid Modulation in Neurodegenerative Diseases: In Pursuit of Certainty
por: Vasincu, Alexandru, et al.
Publicado: (2022)

Development of terphenyl-2-methyloxazol-5(4H)-one derivatives as selective reversible MAGL inhibitors
por: Granchi, Carlotta, et al.
Publicado: (2017)

The Endocannabinoid System: A Putative Role in Neurodegenerative Diseases
por: Di Iorio, Giuseppe, et al.
Publicado: (2013)

Monoacylglycerol Lipase (MAGL) Inhibition Attenuates Acute Lung Injury in Mice
por: Costola-de-Souza, Carolina, et al.
Publicado: (2013)

FAAH selectively influences placebo effects
por: Peciña, M., et al.
Publicado: (2013)

Computationally driven discovery of phenyl(piperazin-1-yl)methanone derivatives as reversible monoacylglycerol lipase (MAGL) inhibitors
por: Poli, Giulio, et al.
Publicado: (2019)

Metabolism and disposition of MM-433593, a selective FAAH-1 inhibitor, in monkeys
por: Banijamali, Ali R, et al.
Publicado: (2014)

Activity of FAAH-Inhibitor JZP327A in an Experimental Rat Model of Migraine
por: Greco, Rosaria, et al.
Publicado: (2023)

Potential Role of Cannabinoid Type 2 Receptors in Neuropsychiatric and Neurodegenerative Disorders
por: Ishiguro, Hiroki, et al.
Publicado: (2022)

MAGL regulates synovial macrophage polarization vis inhibition of mitophagy in osteoarthritic pain
por: Gu, Chengyong, et al.
Publicado: (2023)

Advances in Management of Neuropsychiatric Syndromes in Neurodegenerative Diseases
por: Cummings, Jeffrey, et al.
Publicado: (2019)

The emerging role of furin in neurodegenerative and neuropsychiatric diseases
por: Zhang, Yi, et al.
Publicado: (2022)

The FAAH Inhibitor URB597 Modulates Lipid Mediators in the Brain of Rats with Spontaneous Hypertension
por: Biernacki, Michał, et al.
Publicado: (2020)

Tapetal Expression of BnaC.MAGL8.a Causes Male Sterility in Arabidopsis
por: Gao, Jie, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_q0rg1uj69nt1vo0f0jm22nkp68